Navigation Links
'Undesirable' evolution can be reversed in fish, Stony Brook University scientists show
Date:3/3/2009

STONY BROOK, NY, March 3, 2009 "Undesirable" evolution in fish which makes their bodies grow smaller and fishery catches dwindle -- can actually be reversed in a few decades' time by changing our "take-the-biggest-fish" approach to commercial fishing, according to groundbreaking new research published today by Stony Brook University scientists in Proceedings of the Royal Society B.

Intensive harvesting of the largest fish over many decades, while leaving the small fish behind, may have unintentionally genetically reprogrammed many species to grow smaller, said lead author Dr. David O. Conover, Professor and Dean of the Stony Brook University School of Marine and Atmospheric Sciences in Long Island, New York. Although Charles Darwin showed 150 years ago that evolution equips life forms to be better adapted to prosper in their environment, unnatural evolution caused by man's size-selective fishing is causing fish to be smaller, less fertile, and competitively disadvantaged. This has also been a loss for commercial fishers who seek big fish for their livelihoods, recreational anglers in pursuit of trophy fish, and seafood consumers who desire large portions on their plates.

This study demonstrates for the first time ever that detrimental evolution in fish can be reversed, and pokes a gaping hole in theoretical models suggesting that genetic changes are impossible to "undo." It is the result of 10 years of research largely supported by a generous grant from the Institute for Ocean Conservation Science at Stony Brook University.

"This is good news for fisheries, but it also shows that reversal is a slow process," Dr. Conover said. "Over time, fish can return back to their normal size but the reversal process occurs much more slowly than the changes caused by fishing. So the best strategy is still to avoid harmful evolutionary changes in the first place".

Current fishery management plans are generally based upon asses
'/>"/>

Contact: Kathryn Cervino
kathryn.cervino@stonybrook.edu
347-439-1816
Stony Brook University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Evolutionary biologist will study HIV with grant from AIDS research foundation
2. A revolutionary new model for Alzheimers disease
3. Clemson chemists present revolutionary teaching concepts
4. Evolution education for K-12 teachers needs beefing up, says CU-Boulder professor
5. Pubic hair provides evolutionary home for gorilla lice
6. Singapore-US scientists first to develop revolutionary microchip that uses 30 times less energy
7. Researchers observe evolution chain reaction
8. Comparative genomics reveals molecular evolution of Q fever pathogen
9. Evolution and climate change research advances at Rutgers-Camden
10. Dinosaur fossils fit perfectly into the evolutionary tree of life
11. Billion-year revision of plant evolution timeline may stem from discovery of lignin in seaweed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Undesirable' evolution can be reversed in fish, Stony Brook University scientists show
(Date:3/17/2015)... , March 17, 2015 Emotient, ... analytics software, today announced general availability of ... service for the analysis of facial expressions. The ... advertising, media content, products and services. It delivers ... engagement and sentiment - as derived from facial ...
(Date:3/12/2015)... IriTech, a leading iris based identity management ... Instruments Design Network, announced today that the Chief Minister ... USB MK2120U device during a launching event of Andhra ... The iris scanner is manufactured by U.S. ... India through its Indian partner, Biometronic ...
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March 17, ... here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost & ... - http://photos.prnewswire.com/prnh/20150311/181111 Biometric companies ... compete in several different markets and industries. This ... witnessing an uptrend. Join Frost ...
Breaking Biology News(10 mins):New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... study concludes that models may be predicting releases of ... too low, depending on the region, because they don,t ... of carbon released from soil. The study points ... gas emissions from soils based on "average" projected temperatures. ...
... began studying the origin of life in the early 1980s, ... a major influence on scientific understanding of how life on ... Press, June 2011), Deamer presents a personal history of his ... accessible overview of research into life,s beginnings. The ...
... To mark the International Year of Chemistry, the 94th Canadian ... des congrs de Montral from June 5 to 9, 2011. ... to focus on science and the practice of chemistry. ... the Universit de Montral, and Ann English, director of the ...
Cached Biology News:Climate projections don't accurately reflect soil carbon release 2Climate projections don't accurately reflect soil carbon release 3Biochemist David Deamer explores how life began in new book, 'First Life' 2Healthy dose of chemistry coming to Montreal 2Healthy dose of chemistry coming to Montreal 3
(Date:3/31/2015)... FRANCISCO , March 31, 2015  Sonoa Health, ... Australia , has developed a world-first consumer health ... records, medication prescriptions, wearable devices and more. ... Stewart as its CEO, who brings to the ... corporate advisory, which has included working closely with the ...
(Date:3/31/2015)...   Mapi expands Pharmacovigilance and Risk ... global Risk Management strength with the expanded breadth ... . Pharmacovigilance and Risk ... team that includes physicians, pharmacists, and numerous other ... navigating complex safety requirements throughout the product lifecycle. ...
(Date:3/31/2015)... YORK , March 31, 2015  PlasmaTech ... company advancing protein biologic therapies and oncology supportive ... partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: 128940) ... country,s Ministry of Food and Drug Safety ("MFDS") ... for MuGard, its oncology supportive-care treatment for the ...
(Date:3/31/2015)... March 31, 2015 This June 13th, ... the top U.S and International Medical Schools will come ... research on the application of stem cell therapy in ... is organized and funded by the Ocular Research ... has been convening intimate meetings of top experts in ...
Breaking Biology Technology:Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2
... Ala., July 31 BioCryst,Pharmaceuticals (Nasdaq: BCRX ... results will be released on Thursday, August 7, ... call and Webcast at 8:30 a.m.,Eastern Time to ... on the,Company,s programs. The call will be led ...
... HEIGHTS, N.J., July 31 Genta,Incorporated (OTC Bulletin ... its second quarter 2008 financial results on Thursday, ... call and live audio,webcast to discuss these financial ... Participants can access the live call by dialing ...
... and PHILADELPHIA, July 31 /PRNewswire-FirstCall/,-- Shire Limited (LSE: SHP, NASDAQ: ... months to June,30, 2008., Q2 2008 ... - Product sales excluding ADDERALL XR(R) up 64% to ... sales (2007: 18%) - Total revenues up 35% to ...
Cached Biology Technology:BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 2BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 3Genta Announces Second Quarter 2008 Financial Results and Conference Call 2Genta Announces Second Quarter 2008 Financial Results and Conference Call 3Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 2Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 3Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 4Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 5Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 6Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 7Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 8Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 9Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 10Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 11Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 12Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 13Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 14Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 15Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 16Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 17Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 18Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 19Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 20Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 21Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 22Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 23Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 24Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 25Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 26Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 27Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 28Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 29Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 30Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 31Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade. 32
MOUSE ANTI DUCK IgY LIGHT CHAIN...
Kit for Detection of Mitochondrial Membrane Potential...
For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
...
Biology Products: